诺维信因里程碑付款而季度收入超出预期

路透中文
Aug 06
<a href="https://laohu8.com/S/0Q4U.UK">诺维信</a>因里程碑付款而季度收入超出预期

路透8月6日 - Novavax >周三 公布的第二季度营收超出华尔街预期,这主要得益于其COVID-19疫苗5月份在美国获批后获得了1.75亿美元的里程碑付款。

根据LSEG汇编的数据,这家生物技术公司的总收入为2.39亿美元,而分析师的平均 预期为1.4796亿美元。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10